Juvenescence books

Investing in the Future of Longevity – the Ketone Chapter

10-May-2022

Juvenescence webinar about the latest research and developments on future of longevity investment

David Gill

Chief Financial Officer at Juvenescence

Alexander Pickett

Managing Director at Juvenescence

Richard Marshall

Chief Executive Officer at Juvenescence

Gillian Dines

Chief Science Officer at Juvenescence

Steve Felstead

Chief Medical Officer at Juvenescence

Jim Mellon

British entrepreneur, author and philanthropist with interests across a number of industries

Gregory Bailey

CEO at Juvenescence and chairman of Portage Biotech

Declan Doogan

Co-founder of Juvenescence

Ellen Donnelly

Chief Executive Officer of the Epigenetics Division of Juvenescence Limited

Souvien Therapeutics

Biotech company of the life sciences company Juvenescence is focused on developing new therapies to modulate essential epigenetic mechanisms associated with neurodegeneration

Colin Watts

CEO at Juvenescence Life.

David Roblin

Chief Operating Officer and CEO of Therapeutics Division at Juvenescence